Curetis Prepping Second European Multiplex MDx Panel, Enrolling Trial for First US Panel | GenomeWeb

This article has been updated from a previous version to correct Curetis' planned timeline for US regulatory clearance of its platform.

Having established commercial sales of its Unyvero P50 highly multiplexed pneumonia molecular testing panel in Europe, German molecular diagnostics firm Curetis is now well underway in its efforts to enroll approximately 2,000 patients in the US for a prospective clinical trial to support a regulatory submission for a similar test to the US Food and Drug Administration.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

This week in Nature: Researchers describe the adaptation of organisms to environmental changes, while another study provides new insights into pig domestication.

The blog Sartorial Science seeks to challenge the stereotype of scientists as frumpy, messy, clueless dressers.

While one researcher says cloning the mammoth may be decades away, if successful, it may lead to a theme park of species that would no longer be extinct.

DNA Sequencing is being used by researchers in California to survey fish and marine life as part of a conservation effort.